Display options
Share it on

Oncol Lett. 2016 Jul;12(1):479-484. doi: 10.3892/ol.2016.4665. Epub 2016 Jun 01.

Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis.

Oncology letters

Hiroki Ishihara, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Izumi Fukuda, Tsunenori Kondo, Naomi Hizuka, Yoji Nagashima, Kazunari Tanabe

Affiliations

  1. Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
  2. Department of Hypertension and Endocrinology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
  3. Department of Pathology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

PMID: 27347168 PMCID: PMC4907020 DOI: 10.3892/ol.2016.4665

Abstract

The present study reports a case of recurrent malignant pelvic solitary fibrous tumor (SFT) that induced non-islet cell tumor hypoglycemia via high-molecular-weight insulin-like growth factor-II in a 72-year-old male patient. The tumor recurred ~12 years after the complete resection of the original mass. The recurrent tumor, which had directly invaded the left ureter and perirectal fat tissue, could not be completely excised due to its fragility and adhesiveness. At 13 days post-surgery, the patient presented with rectal perforation, and an urgent rectal resection and colostomy was performed. Neither recurrence of the tumor nor hypoglycemic symptoms were observed 9 months after the surgery. High molecular weight insulin-like growth factor-II was detected in the serum and tumor specimens by western blot analysis and immunohistochemistry. The present case report suggests that certain SFTs can relapse even ≥10 years after a presumed complete resection of the primary tumor, and that performing a safe and complete resection of these tumors can be challenging, due to their adhesiveness or physical presentation; therefore, the indications for surgery should be considered with caution.

Keywords: hypoglycemia; insulin-like growth factor; late recurrence; malignant; solitary fibrous tumor

References

  1. J Endocrinol. 1986 May;109(2):233-8 - PubMed
  2. Nat Genet. 2013 Feb;45(2):131-2 - PubMed
  3. Mod Pathol. 1999 Nov;12(11):1034-42 - PubMed
  4. Am J Surg Pathol. 1989 Aug;13(8):640-58 - PubMed
  5. Lung Cancer. 2009 May;64(2):244-6 - PubMed
  6. N Engl J Med. 1988 Dec 1;319(22):1434-40 - PubMed
  7. Am J Pathol. 2014 Apr;184(4):1209-18 - PubMed
  8. Intern Med. 2012;51(23):3267-72 - PubMed
  9. APMIS. 2000 Sep;108(9):617-25 - PubMed
  10. Mol Cancer Ther. 2010 May;9(5):1286-97 - PubMed
  11. Chest. 2010 Apr;137(4):1005-6 - PubMed
  12. BMC Res Notes. 2012 Oct 29;5:593 - PubMed
  13. Cancer. 1981 Jun 1;47(11):2678-89 - PubMed
  14. Nat Genet. 2013 Feb;45(2):180-5 - PubMed
  15. J Orthop Sci. 2015 Mar;20(2):439-43 - PubMed
  16. Urol Oncol. 2008 May-Jun;26(3):254-9 - PubMed
  17. Intern Med. 2006;45(8):525-9 - PubMed
  18. Clin Sarcoma Res. 2013 Apr 03;3:4 - PubMed
  19. J Thorac Oncol. 2008 Aug;3(8):938-41 - PubMed
  20. Case Rep Oncol. 2012 May;5(2):420-7 - PubMed
  21. Virchows Arch. 1997 Jun;430(6):445-53 - PubMed
  22. Growth Horm IGF Res. 2006 Aug;16(4):211-6 - PubMed
  23. Cancer. 2014 Mar 15;120(6):864-76 - PubMed
  24. J Clin Endocrinol Metab. 1989 Apr;68(4):701-6 - PubMed

Publication Types